Roman Catholic Diocese of La Crosse

ROTH MKM Announces Additions to its SPAC Capital Markets Group

Retrieved on: 
Thursday, August 3, 2023

ROTH MKM today announced that Gil Ottensoser will be joining the firm as Managing Director and Head of SPAC Investment Banking.

Key Points: 
  • ROTH MKM today announced that Gil Ottensoser will be joining the firm as Managing Director and Head of SPAC Investment Banking.
  • In addition to Gil, ROTH MKM recently hired Anthony Mazzurco, Managing Director, Senior SPAC Trader.
  • Most recently, Gil led BTIG’s SPAC effort, as Head of SPAC Banking and Capital Markets.
  • ROTH MKM and affiliated entities, have deep experience through the lifecycle of a SPAC, including SPAC sponsor, IPO, and de-SPAC.

(SPAC) Special Purpose Acquisition Investigation: PRDS, GMTX, SNTI, TNGX - Contact Shareholder Rights Law Firm Johnson Fistel

Retrieved on: 
Wednesday, August 2, 2023

SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of law in connection with the following special purpose acquisition companies ("SPACs"):

Key Points: 
  • SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of law in connection with the following special purpose acquisition companies ("SPACs"):
    Gemini Therapeutics f/k/a FS Development Corp., (NASDAQ: GMTX)
    Senti Biosciences Inc. f/k/a Dynamics Special Purpose Corp (NASDAQ: SNTI):
    Tango Therapeutics, Inc. f/k/a BCTG Acquisition Corp (NASDAQ: TNGX):
    If you are an investor purchasing any of the SPACs below and suffered losses: Click or paste the following web address into your browser to submit your information:
    Shareholders who purchased FS Development Corp II and continue to hold their shares are encouraged to submit their information by following the link below:
    Gemini Therapeutics f/k/a FS Development Corp. (NASDAQ: GMTX):
    Shareholders who purchased FS Development Corp. and continue to hold their shares are encouraged to submit their information by following the link below:
    Senti Biosciences Inc. f/k/a Dynamics Special Purpose Corp (NASDAQ: SNTI):
    Shareholders who purchased Dynamics Special Purpose Corp and continue to hold their shares are encouraged to submit their information by following the link below:
    Tango Therapeutics, Inc. f/k/a BCTG Acquisition Corp (NASDAQ: TNGX):
    Shareholders who purchased BCTG Acquisition Corp and continue to hold their shares are encouraged to submit their information by following the link below:

EF Hutton Announces Appointment of Gaurav Verma as Head of SPACs

Retrieved on: 
Wednesday, August 2, 2023

NEW YORK, NY, Aug. 02, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - EF Hutton, division of Benchmark Investments, LLC (“EF Hutton”), today announced the appointment of Gaurav Verma as Head of SPACs.

Key Points: 
  • NEW YORK, NY, Aug. 02, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - EF Hutton, division of Benchmark Investments, LLC (“EF Hutton”), today announced the appointment of Gaurav Verma as Head of SPACs.
  • Mr. Verma assumed the Head of SPACs position at EF Hutton in July of 2023, previously serving as Managing Director, Investment Banking at EF Hutton since he joined the firm in January of 2021.
  • Prior to joining EF Hutton, Mr. Verma was a Director at Nomura where he spearheaded the Technology, Media, and Telecom (TMT) coverage efforts and executed several financial and strategic transactions.
  • “EF Hutton has maintained its position as a SPAC market leader, from front-end IPO execution through De-SPAC advisory and transaction close.

BTIG Investment Banking Continues to Grow Debt Capital Advisory Team With John Bertrand

Retrieved on: 
Tuesday, August 1, 2023

BTIG announced today that John Bertrand has joined the firm as a Managing Director within Investment Banking’s Debt Capital Advisory Group.

Key Points: 
  • BTIG announced today that John Bertrand has joined the firm as a Managing Director within Investment Banking’s Debt Capital Advisory Group.
  • Based in the New York office, Mr. Bertrand will support the firm’s efforts to originate, structure, and execute debt financing for corporate issuers and financials sponsors.
  • Mr. Bertrand brings more than 25 years of industry experience to the firm.
  • “We are delighted to welcome John to BTIG,” said Anton LeRoy, President of BTIG.

BRW Announces $0.085 Dividend

Retrieved on: 
Tuesday, August 1, 2023

Such average net asset value calculations for a NAV Month will be based on the number of business days in such applicable NAV Month.

Key Points: 
  • Such average net asset value calculations for a NAV Month will be based on the number of business days in such applicable NAV Month.
  • The distribution will be calculated as 12.00% of the applicable NAV Month’s average net asset value, divided by twelve.
  • As a result, long-term capital gains and/or return of capital may be a material source of any distribution.
  • The Board of Trustees (the “Board”) may amend the terms of the plan or terminate the plan at any time.

CSC Appoints John Cuciti as Senior Product and Relationship Manager for Delaware Trust Company

Retrieved on: 
Tuesday, July 25, 2023

CSC, the world’s leading provider of business, legal, tax, and digital brand services, has announced the addition of John Cuciti as senior product and relationship manager.

Key Points: 
  • CSC, the world’s leading provider of business, legal, tax, and digital brand services, has announced the addition of John Cuciti as senior product and relationship manager.
  • In this role, he’ll be responsible for growing and expanding services for the escrow, project finance, and reinsurance trust markets of CSC’s wholly owned and fully regulated subsidiary, Delaware Trust Company .
  • Cuciti will report to Ed Morelli, senior managing director and head of project finance, escrow services and reinsurance trust.
  • He’s a welcome addition to our talented and successful corporate trust and agency team.”
    “I am beyond thrilled to join Delaware Trust,” said Cuciti.

(SPAC) Special Purpose Acquisition Investigation: BHIL, RSI - Contact Shareholder Rights Law Firm Johnson Fistel

Retrieved on: 
Friday, July 21, 2023

SAN DIEGO, July 21, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of law in connection with the following special purpose acquisition companies ("SPACs"):

Key Points: 
  • SAN DIEGO, July 21, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of law in connection with the following special purpose acquisition companies ("SPACs"):
    Benson Hill, Inc. f/k/a Crest Investment Corporation (NYSE: BHIL)
    If you are an investor purchasing any of the SPACs below and suffered losses: Click or paste the following web address into your browser to submit your information:
    Benson Hill, Inc. f/k/a Star Peak Corp II: https://www.johnsonfistel.com/investigations/benson-hill-inc-f-k-a-crest...

(SPAC) Special Purpose Acquisition Investigation: PRDS, GMTX, SNTI, TNGX - Contact Shareholder Rights Law Firm Johnson Fistel

Retrieved on: 
Friday, July 21, 2023

SAN DIEGO, July 21, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of law in connection with the following special purpose acquisition companies ("SPACs"):

Key Points: 
  • SAN DIEGO, July 21, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of law in connection with the following special purpose acquisition companies ("SPACs"):
    Gemini Therapeutics f/k/a FS Development Corp., (NASDAQ: GMTX)
    Senti Biosciences Inc. f/k/a Dynamics Special Purpose Corp (NASDAQ: SNTI):
    Tango Therapeutics, Inc. f/k/a BCTG Acquisition Corp (NASDAQ: TNGX):
    If you are an investor purchasing any of the SPACs below and suffered losses: Click or paste the following web address into your browser to submit your information:
    Shareholders who purchased FS Development Corp II and continue to hold their shares are encouraged to submit their information by following the link below:
    Gemini Therapeutics f/k/a FS Development Corp. (NASDAQ: GMTX):
    Shareholders who purchased FS Development Corp. and continue to hold their shares are encouraged to submit their information by following the link below:
    Senti Biosciences Inc. f/k/a Dynamics Special Purpose Corp (NASDAQ: SNTI):
    Shareholders who purchased Dynamics Special Purpose Corp and continue to hold their shares are encouraged to submit their information by following the link below:
    Tango Therapeutics, Inc. f/k/a BCTG Acquisition Corp (NASDAQ: TNGX):
    Shareholders who purchased BCTG Acquisition Corp and continue to hold their shares are encouraged to submit their information by following the link below:

(SPAC) Special Purpose Acquisition Investigation: FFIE, NRGV, CELU, EMBK Contact Shareholder Rights Law Firm Johnson Fistel

Retrieved on: 
Friday, July 21, 2023

SAN DIEGO, July 21, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of law in connection with the following special purpose acquisition companies ("SPACs"):

Key Points: 
  • SAN DIEGO, July 21, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of law in connection with the following special purpose acquisition companies ("SPACs"):
    Faraday Future Intelligent Electric Inc. f/k/a Property Solutions Acquisition Corp. (NASDAQ FFIE)
    Embark Technology Inc. f/k/a Northern Genesis Acquisition Corp. II (NASDAQ: EMBK)
    If you are an investor who has suffered losses in connection with any of the SPACs purchased below: Click or paste the following web address into your browser to submit your losses:
    Faraday Future Intelligent Electric Inc. f/k/a Property Solutions Acquisition Corp. (NASDAQ FFIE)
    Shareholders who purchased Property Solutions Acquisition Corp. and continue to hold their shares are encouraged to submit their information by following the link below:
    Shareholders who purchased Novus Capital Corp. II and continue to hold their shares are encouraged to submit their information by following the link below:
    Shareholders who purchased GX Acquisition Corp. and continue to hold their shares are encouraged to submit their information by following the link below:
    Embark Technology Inc. f/k/a Northern Genesis Acquisition Corp. II (NASDAQ: EMBK)
    Shareholders who purchased Northern Genesis Acquisition Corp. II and continue to hold their shares are encouraged to submit their information by following the link below:

(SPAC) Special Purpose Acquisition Investigation: BHIL, RSI - Contact Shareholder Rights Law Firm Johnson Fistel

Retrieved on: 
Friday, July 14, 2023

SAN DIEGO, July 14, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of law in connection with the following special purpose acquisition companies ("SPACs"):

Key Points: 
  • SAN DIEGO, July 14, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of law in connection with the following special purpose acquisition companies ("SPACs"):
    Benson Hill, Inc. f/k/a Crest Investment Corporation (NYSE: BHIL)
    If you are an investor purchasing any of the SPACs below and suffered losses: Click or paste the following web address into your browser to submit your information:
    Benson Hill, Inc. f/k/a Star Peak Corp II: https://www.johnsonfistel.com/investigations/benson-hill-inc-f-k-a-crest...